The FDA tends to be pretty hands-off with topical skincare ingredients, except in the case of sunscreen. The FDA oversees ...

There are four classes of anti-infectives used for BRD treatment. It is impotant to use the correct class of antibiotic to ...

When Kelly Todd, 46, entered secondary care for weight management on the NHS four years ago, she quickly realised it would take her years rather than months to the weight-loss drugs she needed. She ...

Thames Valley Police has revealed today (Sunday, February 15) that it has handed out cautions to several people in Banbury, after they were searched. A spokesperson for the Cherwell unit said: "Over ...

Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer's survival. If one component of the complex is ...

Drug Farm Announces FDA Fast Track Designation for First-in-Class ALPK1 Inhibitor DF-003 for the Treatment of ROSAH Syndrome Drug Farm, a clinical-stage biopharmaceutical company advancing two novel ...

Grocery chain Albertsons, which offers pharmacies, is suing the Cigna-owned pharmacy benefit manager Express Scripts for at least $10.9 million over alleged prescription underpayments, according to a ...

Cartel Expert Becomes First Woman to Lead Nation’s Drug Control Policy Today, in a 52-48 vote, United States Senate confirmed Sara Carter as the 10 th Director of the White House Office of National ...

There is no biological measure for wakefulness. In a narcolepsy clinical trial, a patient lies down in a dark lab while clinicians count the minutes until sleep comes. The average time in four tests ...

Individuals with HIV who were resistant to all four antiretroviral drug classes experienced higher mortality than those who were not resistant, a difference primarily due to lower CD4 cell counts.

A research team at McMaster University has discovered a new drug class that could someday lead to breakthrough treatments for dangerous fungal infections. The new molecules, dubbed coniotins, were ...

Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new small-molecule drug class. The pact’s potential value includes an undisclosed ...